TransMedics to Host Investor & Analyst Day on December 10, 2024
TransMedics to Host Investor & Analyst Day on December 10, 2024
In-person attendance at the event requires advanced registration. Please email ANDOVER, Mass., Nov. 26, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that it will host an Investor & Analyst Day in New York City on Tuesday, December 10, 2024, at 10:00 AM ET.
馬薩諸塞州安多弗，2024年11月26日 /PRNewswire/ — 正在改變終末期肺部、心臟和肝衰竭患者器官移植療法的醫療技術公司TransMedics Group, Inc.（「TransMedics」）（納斯達克股票代碼：TMDX）今天宣佈，將於美國東部時間2024年12月10日星期二上午10點在紐約市舉辦投資者和分析師日。
Waleed Hassanein, MD., President and Chief Executive Officer, and members of the leadership team will present an overview of TransMedics' growth strategy, clinical pipeline, and operations.
總裁兼首席執行官瓦利德·哈薩內因醫學博士和領導團隊成員將概述TransMedics的增長戰略、臨床產品線和運營。
A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at . Please note management will only take questions from the live audience during the question-and-answer session following the formal presentations.
TransMedics網站的 「投資者」 部分將提供演講和問答環節的網絡直播和存檔直播，網址爲。請注意，管理層只會在正式演講後的問答環節中向現場觀衆提問。
In-person attendance at the event requires advanced registration. Please email Laine Morgan at [email protected] by December 4, 2024, for further information.
面對面參加活動需要提前註冊。請在 2024 年 12 月 4 日之前向 Laine Morgan 發送電子郵件至 [email protected] 以獲取更多信息。
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
關於 TransMedics 集團有限公司
TransMedics是便攜式體外熱灌注和移植供體器官評估領域的全球領導者。該公司總部位於馬薩諸塞州安多弗，成立的目的是解決對更多更好的移植器官的未得到滿足的需求，並開發了保護器官質量、在移植前評估器官活力的技術，並有可能提高捐贈器官在治療終末期心臟、肺和肝衰竭方面的利用率。
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
[email protected]
投資者聯繫人：
布萊恩·約翰斯頓
萊恩·摩根
332-895-3222
[電子郵件保護]
SOURCE TransMedics Group, Inc.
來源 TransMedics Group, Inc.
